The EU’s drugs regulator has set up a fast-track system to monitor shortages during the COVID-19 pandemic.
Greece has reportedly suggested that EU member states should jointly buy patent rights for COVID-19 tests and vaccines to ensure rapid distribution across the EU.
Notorious ‘pharma bro’ Martin Shkreli and his former drug company Retrophin want antitrust claims filed against them in federal court dismissed.
Mewburn Ellis has appointed a new life sciences-focused partner as part of a number of promotions in its IP team.
The Biotechnology Innovation Organization has converted its 2020 international convention into an entirely online experience, BIO Digital.
A British man has been charged with smuggling mislabelled drugs, purporting to be a treatment for those suffering from COVID-19, into the US.
France’s Sanofi Pasteur and US biotechnology company Translate Bio have joined the race to develop a vaccine for SARS-CoV-2, the coronavirus behind COVID-19.
A court has rejected Gilead’s attempt to overturn a $752 million verdict in a patent dispute with BMS’ Juno Therapeutics over CAR-T therapies.
IP law firm EIP has enhanced its life science capabilities with the addition of Monika Rai as a partner.
Almost 150 health and poverty activist campaigns, including Médecins Sans Frontières, have urged Gilead Sciences to waive patent and exclusivity rights for potential COVID-19 treatment remdesivir.